Shiloh
Editor, Senior Moderator
Source: https://www.cnbc.com/2019/04/08/can...mise-in-human-trial-of-lymphoma-patients.html
Cancer 'vaccine' shows promise in human trial of lymphoma patients
An experimental cancer vaccine showed promise in a small clinical trial, according to a study in Nature Medicine.
Mount Sinai tested the treatment in 11 patients with lymphoma.
The vaccine is used in people who already have cancer. It's not preventive like the flu shot.
Angelica LaVito
Published 2 Hours Ago Updated 4 Mins Ago CNBC.com
An experimental cancer "vaccine" showed promising results in a small clinical trial of patients with lymphoma, according to a study published Monday in the journal Nature Medicine.
Researchers at New York's Mount Sinai Hospital tested the treatment in 11 patients with lymphoma. Their results were successful enough to warrant another clinical trial in March on lymphoma patients as well as breast and head-and-neck cancer...
Researchers said some patients in the initial human trial went into full remission for months or even years.
The treatment "has broad implications for multiple types of cancer," said lead author, Dr. Joshua Brody, director of the lymphoma immunotherapy program. "This method could also increase the success of other immunotherapies such as checkpoint blockade."
Cancer 'vaccine' shows promise in human trial of lymphoma patients
An experimental cancer vaccine showed promise in a small clinical trial, according to a study in Nature Medicine.
Mount Sinai tested the treatment in 11 patients with lymphoma.
The vaccine is used in people who already have cancer. It's not preventive like the flu shot.
Angelica LaVito
Published 2 Hours Ago Updated 4 Mins Ago CNBC.com
An experimental cancer "vaccine" showed promising results in a small clinical trial of patients with lymphoma, according to a study published Monday in the journal Nature Medicine.
Researchers at New York's Mount Sinai Hospital tested the treatment in 11 patients with lymphoma. Their results were successful enough to warrant another clinical trial in March on lymphoma patients as well as breast and head-and-neck cancer...
Researchers said some patients in the initial human trial went into full remission for months or even years.
The treatment "has broad implications for multiple types of cancer," said lead author, Dr. Joshua Brody, director of the lymphoma immunotherapy program. "This method could also increase the success of other immunotherapies such as checkpoint blockade."